JPMorgan Reiterates Neutral Rating on Pfizer (PFE)
Tweet Send to a Friend
JPMorgan analyst Chris Schott reiterated a Neutral rating and $30.00 price target on Pfizer (NYSE: PFE).The analyst comments "Exiting PFE’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


